Rivard K, Trépanier-Boulay V, Rindt H, Fiset C. Electrical remodeling in a transgenic mouse model of ␣ 1B-adrenergic receptor overexpression. Am J Physiol Heart Circ Physiol 296: H704 -H718, 2009. First published December 26, 2008 doi:10.1152/ajpheart.00337.2008.-Cardiac-specific overexpression of wild-type ␣ 1B-adrenergic receptors (␣ 1B-AR) in mice predisposes to dilated cardiomyopathy and sudden death. Although ␣-adrenergic stimulation is thought to contribute to induction of arrhythmias in heart failure, the electrophysiological consequences of chronic ␣ 1-adrenergic activation have not been clearly defined. Thus we characterized ventricular repolarization and monitored incidence of spontaneous arrhythmias in end-stage heart failure ␣ 1B-AR mice (9 -12 mo) and younger ␣1B-AR mice (2-3 mo) that do not present signs of heart failure. Compared with agedmatched controls, the corrected QT interval was 34% longer in the 9-to 12-mo ␣ 1B-AR mice, and the action potential durations were also significantly prolonged in these mice. These changes were associated with a decrease in the density of the outward K ϩ currents, Ca 2ϩ -independent transient, ultrarapid delayed rectifier, and steady state (at ϩ30 mV, reduction of 68, 64, and 41%, respectively), and underlying K ϩ channel expression. Electrocardiogram (ECG) recordings revealed that older ␣ 1B-AR mice exhibited spontaneous ventricular arrhythmias. The alterations in repolarization can contribute to these rhythm abnormalities and are likely caused by chronic ␣ 1B-AR activity. Additional data obtained in 2-to 3-mo ␣ 1B-AR mice clearly showed that electrical remodeling was already observed in younger transgenic animals. However, it appeared to be slightly less pronounced than in older mice. These results suggest that there are two waves of remodeling: one due to chronic ␣ 1B-AR activity, and a second due to heart failure. Taken together, these data provide strong evidence for a pathological role of chronic ␣ 1B-AR activity in the development of repolarization defects and ventricular arrhythmias. mouse ventricle; arrhythmias; K ϩ currents THE SYMPATHETIC NERVOUS SYSTEM plays a crucial role in the regulation of cardiac function. Evidence suggests the involvement of ␣ 1 -adrenergic receptors in different types of cardiac dysfunctions. For instance, enhanced ␣ 1 -adrenergic receptor activity has been shown to be involved in cardiac ischemia, ischemic preconditioning, cardiac hypertrophy, heart failure, and arrhythmias (13,39,45). Several subtypes of ␣ 1 -adrenergic receptors coexist in the heart (␣ 1A , ␣ 1B , and ␣ 1D ) (13, 38). Pharmacological studies, as well as transgenic animal models, have been used to identify important physiological and pathological roles of ␣ 1 -adrenergic receptor subtypes in the heart. Based on these studies, the ␣ 1B -adrenergic receptor (␣ 1B -AR) appears to be the major subtype of cardiac ␣ 1 -adrenoceptors under both physiological and pathological conditions (1,8,13,17,28,48).Consistent with an important role in cardiac pathology, Lemire...